monomethylpropion (methcathinone)

01/01/2018 - "Methcathinone-induced Parkinsonism is a recently described extrapyramidal syndrome characterized by globus pallidus and substantia nigra lesions, which provides a unique model of basal ganglia dysfunction. "
01/01/2018 - "Dissociation of reward and effort sensitivity in methcathinone-induced Parkinsonism."
11/01/2016 - "Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome."
01/01/2015 - "Methcathinone could have additive neurotoxic effect to the progression of parkinsonism. "
01/01/2015 - "Methcathinone abuse is a significant cause of parkinsonism among young patients in the Eastern European countries. "

01/01/2014 - "Brain MRI is helpful in the assessment of distribution as well as dynamics of changes in ephedrone encephalopathy. "
10/01/2020 - "Neuropathological Findings in Ephedrone Encephalopathy."
09/01/2015 - "However, no report has ever been published on ephedrone encephalopathy in Polish patients. "
01/01/2014 - "Although brain MRI findings are not characteristic for ephedrone encephalopathy, they may contribute to diagnosing this condition."
07/15/2007 - "Manganic encephalopathy due to "ephedrone" abuse."

02/01/2014 - "No improvement in this Mn-induced movement disorder occurs after cessation of methcathinone abuse despite improvement of Mn blood levels and/or MRI abnormalities. "
11/01/2016 - "Underlying the distinctive movement disorder caused by methcathinone abuse, there is a more widespread pattern of brain involvement than is evident from the hyperintensity restricted to the basal ganglia as shown by T1-weighted structural MRI."
02/01/2014 - "The outcome of the movement disorder in methcathinone abusers: clinical, MRI and manganesemia changes, and neuropathology."
02/01/2014 - "There is limited knowledge regarding the long-term outcome of the methcathinone/manganese-induced movement disorder. "
09/01/2012 - "First, we review the movement disorders that may develop from the acute use or withdrawal of frequent drugs of abuse, including alcohol, cocaine, heroin, amphetamine and methcathinone. "

09/01/2020 - "The two hydrogen atoms eliminated during the dehydration of cathinone (primary amine) and methcathinone (secondary amine) were determined, and the reaction mechanism was elucidated through the deuterium labeling experiments. "

10/15/1998 - "PET studies were performed in 10 control subjects, six abstinent methamphetamine users, four abstinent methcathinone users, and three patients with Parkinson's disease (PD). "
08/01/2016 - "We performed a focus perceptual study of dysarthria in Ephedrone induced parkinsonism and compared the findings with the speech disorders seen in Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP). "
01/01/2015 - "Speech samples based on repetition of the syllable /pa/ at a self-determined steady pace were acquired from 109 subjects, including 22 with Parkinson's disease (PD), 11 progressive supranuclear palsy (PSP), 9 multiple system atrophy (MSA), 24 ephedrone-induced parkinsonism (EP), 20 Huntington's disease (HD), and 23 healthy controls. "